Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mortalin controls centrosome duplication via modulating centrosomal localization of p53

Abstract

Abnormal amplification of centrosomes, commonly found in human cancer, is the major cause of mitotic defects and chromosome instability in cancer cells. Like DNA, centrosomes duplicate once in each cell cycle, hence the defect in the mechanism that ensures centrosome duplication to occur once and only once in each cell cycle results in abnormal amplification of centrosomes and mitotic defects. Centrosomes are non-membranous organelles, and undergo dynamic changes in its constituents during the centrosome duplication cycle. Through a comparative mass spectrometric analysis of unduplicated and duplicated centrosomes, we identified mortalin, a member of heat shock protein family, as a protein that associates preferentially with duplicated centrosomes. Further analysis revealed that mortalin localized to centrosomes in late G1 before centrosome duplication, remained at centrosomes during S and G2, and dissociated from centrosomes during mitosis. Overexpression of mortalin overrides the p53-dependent suppression of centrosome duplication, and mortalin-driven centrosome duplication requires physical interaction between mortalin and p53. Moreover, mortalin promotes dissociation of p53 from centrosomes through physical interaction. The p53 mutant that lacks the ability to bind to mortalin remains at centrosomes, and suppresses centrosome duplication in a transactivation function-independent manner. Thus, our present findings not only identify mortalin as an upstream molecule of p53 but also provide evidence for the involvement of centrosomally localized p53 in the regulation of centrosome duplication.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR, Stark GR . (1995). Proc Natl Acad Sci USA 92: 8493–8497.

  • Blair Zajdel ME, Blair GE . (1988). Oncogene 2: 579–584.

  • Brown CR, Doxsey SJ, White E, Welch WJ . (1994). J Cell Physiol 160: 47–60.

  • Brummelkamp TR, Bernards R, Agami R . (2002). Science 296: 550–553.

  • Ciciarello M, Mangiacasale R, Casenghi M, Zaira Limongi M, D'Angelo M, Soddu S et al. (2001). J Biol Chem 276: 19205–19213.

  • Crook T, Marston NJ, Sara EA, Vousden KH . (1994). Cell 79: 817–827.

  • D'Assoro AB, Lingle WL, Salisbury JL . (2002). Oncogene 40: 6146–6153.

  • Fukasawa K . (2005). Cancer Lett 230: 6–19.

  • Hadari YR, Haring HU, Zick Y . (1997). J Biol Chem 272: 657–662.

  • Hinchcliffe EH, Sluder G . (2002). Oncogene 21: 6154–6160.

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . (1991). Science 253: 49–53.

  • Kaul SC, Reddel RR, Mitsui Y, Wadhwa R . (2001). Neoplasia 3: 110–114.

  • Kaul SC, Taira K, Pereira-Smith OM, Wadhwa R . (2002). Exp Gerontol 37: 1157–1164.

  • Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T et al. (2004). Cancer Res 64: 4800–4809.

  • Lange BM, Gull K . (1996). Trends Cell Biol 6: 348–352.

  • Morris VB, Brammall J, Noble J, Reddel R . (2000). Exp Cell Res 256: 122–130.

  • Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA et al. (2000). Oncogene 19: 1635–1646.

  • Oakley BR . (2000). Curr Top Dev Biol 49: 27–54.

  • Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK et al. (2000). Cell 103: 127–140.

  • Ran Q, Wadhwa R, Kawai R, Kaul SC, Sifers RN, Bick RJ et al. (2000). Biochem Biophys Res Commun 275: 174–179.

  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . (1990). Cell 63: 1129–1136.

  • Stewart N, Hicks GG, Paraskevas F, Mowat M . (1995). Oncogene 10: 109–115.

  • Tarapore P, Fukasawa K . (2002). Oncogene 21: 6234–6240.

  • Tarapore P, Horn HF, Tokuyama Y, Fukasawa K . (2001a). Oncogene 20: 3173–3184.

  • Tarapore P, Tokuyama Y, Horn HF, Fukasawa K . (2001b). Oncogene 20: 6851–6863.

  • Timson J . (1975). Mutat Res 32: 115–132.

  • Tsujimoto Y . (1998). Genes Cells 3: 697–707.

  • Wadhwa R, Kaul SC, Mitsui Y, Sugimoto Y . (1993). Exp Cell Res 207: 442–448.

  • Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, Kaul SC . (1995). Exp Cell Res 216: 101–106.

  • Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR et al. (1998). J Biol Chem 273: 29586–29591.

  • Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR, Kaul SC . (2002). Exp Cell Res 274: 246–253.

Download references

Acknowledgements

We thank K George for technical assistance. This work was supported in part by National Institute of Health (CA90522 and CA95925).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Fukasawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, Z., Izumi, H., Kanai, M. et al. Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 25, 5377–5390 (2006). https://doi.org/10.1038/sj.onc.1209543

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209543

Keywords

This article is cited by

Search

Quick links